DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The "Stroke Management Market by Type (Diagnostics, and Therapeutics) and by Application (Ischemic Stroke, and Haemorrhagic Stroke) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

Stroke occurs due to interruptions in the blood supply to brain, either due to the rupture or blockage of blood vessels, leading to the death of brain cells. Stroke is one of the leading cause of death worldwide, with higher prevalence in the old age population. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centres for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around $34 billion each year in U.S. Hence, there is an impending need for early diagnostic devices and therapeutics to prevent deaths from stroke.

The major factors driving the stroke diagnostics and therapeutics market are large patient pool along with rising aging population. The patients at risk of developing stroke, mainly those suffering from hypertension, atrial fibrillation and coronary heart diseases, would further fuel the market growth. Other factors leading to market growth are rising incidences of diabetes and large number of tobacco users. However, high cost of treatment and lack of transparent reimbursement scenario, are likely to restrict the market growth.

The global stroke diagnostic and therapeutic market, is segmented on the basis of type, application and geography. According to type, the market is segmented into diagnostics and therapeutics. Diagnostic market is further sub-segmented into Computed Tomography Scan (CT scan), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and others. Therapeutic market is further sub-segmented into Tissue Plasminogen Activator, Anticoagulant, Antiplatelet and Antihypertensive. The market is also segmented on the basis of application into Ischemic Stroke and Haemorrhagic Stroke.

Companies Mentioned:

Silk Road Medical, Inc. Abbott Laboratories Medtronic plc Boston Scientific Corporation Cordis Corporation Koninklijke Philips N.V. GE Healthcare Siemens AG Stryker Corporation Genentech, Inc. Merck & Co., Inc.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Stroke Management Market, by Type

5 Stroke Management Market, by Application

6 Stroke Management Market, by Region

7 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/9lfkkp/global_stroke?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612006008/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiology

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 10:42 AM/DISC: 06/12/2018 10:42 AM

http://www.businesswire.com/news/home/20180612006008/en